2.6.2 Calcium-channel blockers
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
| Cardiovascular system | Hypertension |
| Musculoskeletal and joint diseases | Raynaud’s Phenomenon |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
| Cardiovascular system | Hypertension |
| Musculoskeletal and joint diseases | Raynaud’s Phenomenon |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
| Musculoskeletal and joint diseases | Raynaud’s Phenomenon |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Cardiovascular conditions in specialist settings |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Cardiovascular conditions in specialist settings |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
| Musculoskeletal and joint diseases | Raynaud’s Phenomenon |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
| Musculoskeletal and joint diseases | Raynaud’s Phenomenon |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
| Musculoskeletal and joint diseases | Raynaud’s Phenomenon |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Cardiovascular conditions in specialist settings |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
| Cardiovascular system | Atrial fibrillation |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Cluster headache |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Cluster headache |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Angina |
| Cardiovascular system | Atrial fibrillation |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Cluster headache |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Cluster headache |